Brazilian medicinal plant acts on prostaglandin level and Helicobacter pylori

Journal of Medicinal Food

Volumn 11, Issue 4, 2008, Pages 701-708

  Lima, Z P ^a   Calvo, T R ^a   Silva, E F ^b   Pellizzon, C H ^a   Vilegas, W ^a   Brito, A R M S ^b   Bauab, T M ^a   Hiruma Lima, C A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Alchornea triplinervia; Flavonoids; Gastroprotective action; Helicobacter pylori; Prostaglandin E2

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCHORNEA TRIPLINERVIA EXTRACT; CARBENOXOLONE; CIMETIDINE; FLAVONOID; INDOMETACIN; LANSOPRAZOLE; METHANOL; N ETHYLMALEIMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROSTAGLANDIN E2; STOMACH SECRETION INHIBITOR; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BRAZIL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MOUSE; FEMALE; HELICOBACTER PYLORI; INHIBITION KINETICS; LIQUID LIQUID EXTRACTION; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PHYTOCHEMISTRY; PRIORITY JOURNAL; PYLORUS LIGATION; RAT; SINGLE DRUG DOSE; STOMACH INJURY; STOMACH LESION; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH SECRETION; STOMACH ULCER; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BRAZIL; DOSE-RESPONSE RELATIONSHIP, DRUG; EUPHORBIACEAE; FEMALE; FLAVONOIDS; GASTRIC JUICE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PROSTAGLANDINS; RATS; RATS, WISTAR; STOMACH ULCER;

ALCHORNEA TRIPLINERVIA; HELICOBACTER PYLORI; MUS; RATTUS;

EID: 57349125108     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0676     Document Type: Article

References (37)

1. Jain KS, Shah AK, Bariwal J, Shelke SM, Kale AM, Jagtap JR, Bhosale AV: Recent advances in proton pump inhibitors and management of acid-peptic disorders. Bioorg Med Chem 2007;15:1181-1205.
2. Chan FKL, Leung WK: Peptic-ulcer disease. Lancet 2002;360:933-941.
3. Ramakrishnan K, Salinas RC: Peptic ulcer disease. Am Fam Physician 2007;76:1005-1012.
4. Schmeda-Hirschmann G, Yesilada E: Traditional medicine and gastroprotective crude drugs. J Ethnopharmacol 2005;100:61-66.
5. Silva EM, Hiruma-Lima CA, Lólis SF: Etnobotânica no município de Porto Nacional [abstract]. In: Symposium of Brazilian Medicinal Plants. Universidade Federale de Mato Grosso, Cuiabá, Brazil, 2000, p. 106.
6. Braca A, Mendez J, Menichini F, Morelli I: Constituents of Alchornea triplinervia (Euphorbiaceae). Biochem Syst Ecol 2002;30:1109-1111.
7. Manga MH, Brkic D, Marie DEP, Quetin-Leclerc Q: In vivo antiinflammatory activity of Alchornea cordifolia (Schumach & Thonn.) Müll. Arg. (Euphorbiaceae). J Ethnopharmacol 2004;92:209-214.
8. Hiruma-Lima CA, Calvo TR, Rodrigues CM, Andrade FD, Vilegas W, Brito AR: Antiulcerogenic activity of Alchornea castaneaefolia: effects on somatostatin, gastrin and prostaglandin. J Ethnopharmacol 2006;104:215-224.
9. Calvo TR, Lima ZP, Silva JS, Ballesteros KV, Pellizzon CH, Hiruma-Lima CA, Tamashiro J, Brito ARMS, Takahira RK, Vilegas W: Constituents and antiulcer effect of Alchornea glandulosa: activation of cell proliferation in gastric mucosa during the healing process. Biol Pharm Bull 2007;30:451-459.
10. Ebi GC: Antimicrobial activities of Alchornea cordifolia. Fitoterapia 2001;72:69-72.
11. Wagner H, Bladt H, Zgainski EM: Plant Drug Analysis. Springer, Berlin, 1984.
12. Olfert ED, Cross BM, McWilliam AA: Guide to the Care and Use of Experimental Animals. Canadian Council on Animal Care, Ottawa, 1993.
13. Souza-Brito ARM: Manual de Ensaios Toxicológicos In Vivo. Editora da Unicamp, Campinas, Brazil, 1995, pp. 15-22.
14. Mizui T, Douteuchi M: Effect of polyamines on acidified ethanol-induced gastric lesions in rats. Jpn J Pharmacol 1983;33:934-945.
15. Szelenyi I, Thiemer K: Distention ulcer as a model for testing of drugs for ulcerogenic side effects. Arch Toxicol 1978;41:99-105.
16. Morimoto Y, Shimohara K, Oshima S, Sukamoto T: Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal. Jpn J Pharmacol 1991;57:595-605.
17. Puscas I, Puscas C, Coltau M, Pasça R, Torres J, Márquez M, Herrero E, Fillat O, Ortiz J: Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions. Arzneimittelforschung 1997;47:568-572.
18. Shay H, Komarov SA, Fels SS, Meranze D, Gruenstein M, Siplet H: A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 1945;5:43-61.
19. Arrieta J, Benitez J, Flores E, Castillo C, Navarrete A: Purification of gastroprotective triterpenoids from the stem bark of Amphipterygium adstringens; role of prostaglandins, sulfhydryls, nitric oxide and capsaicin-sensitive neurons. Planta Med 2003;69:905-909.
20. Curtis GH, MacNaughton WK, Gall DG, Wallace JL: Intraluminal pH modulates gastric prostaglandin synthesis. Can J Physiol Pharmacol 1995;73:130-134.
21. Hacem CY, Clarridge JE, Reddy R, Flamm R, Evans DG, Tanaka SK, Graham DY: Antimicrobial susceptibility testing of Helicobacter pylori. Diagn Microbiol Infect Dis 1996;41:24-37.
22. Ekwall B, Ekwall K: Comments on the use of diverse cell systems in toxicity testing. Altern Lab Anim 1988;15:193-200.
23. Konturek PC, Brzowski T, Sliwoswski Z: Involvement of nitric oxide and prostaglandin in gastroprotection induced by bacterial lipopolysaccharide. Scand J Gastroenterol 1988;33:691-700.
24. Peng S, Duggan A: Gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Expert Opin Drug Safety 2005;4:157-169.
25. Wolfe MM, Lynda S, Sachs G: Proton pump inhibitors and gastric acid secretion. Am J Gastroenterol 2001;96:3467-3468.
26. Peskar BM, Maricic N: Role of prostaglandins in gastroprotection. Dig Dis Sci 1998;43(Suppl):23S-29S.
27. Gracioso JS, Vilegas W, Hiruma-Lima CA, Souza-Brito ARM: Effects of tea from Turnera ulmifolia L. on mouse gastric mucosa support the Turneraceae as a new source of antiulcerogenic drugs. Biol Pharm Bull 2002;25:470-491.
28. Repetto MG, Llesuy SF: Antioxidant properties of natural compounds used in popular medicine for gastric ulcers. Braz J Med Biol Res 2002;35:523-534.
29. Brodie BB, Costa E, Dlabac A, Neff NH, Smookler HH: Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J Pharmacol Exp Ther 1966;154:493-498.
30. Rastogi L, Patnaik GK, Dikshit M: Free radicals and antioxidant status following pylorus ligation induced gastric mucosal injury in rats. Pharmacol Res 1998;38:125-132.
31. Szabo S, Trier JS, Frankel PW: Sulfhydryl compounds may mediate gastric cytoprotection. Science 1981;214:200-202.
32. Lopez A, Motilva V, Alarcón de la Lastra C, Martin MJ, La Casa C: The role of gastric mucosal sulphydryls in the ulcer-protecting effects of cisapride. J Pharm Pharmacol 1996;48:37-40.
33. Laine L, Weinstein WM: Histology of alcoholic hemorrhagic "gastritis," a prospective evaluation. Gastroenterology 1988;94:1254-1262.
34. Szallasi A, Biro T, Modarres S, Garlaschelli L, Petersen M, Klusch A, Vidari G, Jonassohn M, De Rosa S, Sterner O, Blumberg PM, Krause JE: Dialdehyde sesquiterpenes and other terpenoids as vanilloids. Eur J Pharmacol 1998;356:81-89.
35. Gadhi CA, Benharref A, Jana M, Lozniewski A: Anti-Helicobacter pylorus activity of Aristolochia paucinervis pomel extracts. J Ethnopharmacol 2001;75:203-205.
36. Arakawa T, Higuchi K, Fukuda T, Fujiwara Y, Kobayashi K, Kuroki T: Prostaglandins in the stomach: an update. J Clin Gastroenterol 1998;27(Suppl):S1-S11.
37. Park S, Hahm K, Oh T, Jin J, Choue R: Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosa damage in rats. Dig Dis Sci 2004;49:384-394.